A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)

Overview of attention for article published in BMC Cancer, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,091 followers.

Check out our recently published phase II trial protocol of the NATCHO trial! Lucky to work with the best @CharbelEliass, @ZeidanMd @dmukherji Trial lead by Professor Ali Shamseddine!

16 Dec 2022

Reply Repost Favourite

Happy to share my newly published paper in BMC Cancer: a study protocol involving Nivolumab + SBRT, after induction chemotherapy, in cholangiocarcinoma. Check it out: https://t.co/b9uGgJijer https://t.co/njLA8x9GTx

15 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.